Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

78.41 USD +0.63 (+0.81%)
Official Closing Price Updated: 7:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,677,023
Open 78.01
Bid (Size) 78.32 (1)
Ask (Size) 78.40 (6)
Prev. Close 77.78
Today's Range 77.89 - 78.66
52wk Range 71.71 - 87.80
Shares Outstanding 2,532,058,364
Dividend Yield 3.32%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Merck Declares Record Date and Dividend for the Organon & Co. Spinoff
Merck Declares Record Date and Dividend for the Organon & Co. Spinoff 
From Business Wire News Releases
Merck Highlights Scientific Data at 2021 ASCO Annual Meeting Across More Than 20 Cancer Types From Broad Oncology Research Program
Merck Highlights Scientific Data at 2021 ASCO Annual Meeting Across More Than 20 Cancer Types From Broad Oncology Research Program 
From Business Wire News Releases

Performance

YTD
-3.15%
-3.15%
1 Month
+3.01%
+3.01%
3 Month
+3.44%
+3.44%
6 Month
-2.43%
-2.43%
1 Year
+3.72%
+3.72%

More News

Read More
Merck and Eisai Receive Priority Review From FDA for KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Applications for Advanced Renal Cell Carcinoma and for Advanced Endometrial Carcinoma
From Business Wire News Releases
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophage
From Business Wire News Releases
Interesting MRK Put And Call Options For June 25th
Tags Stocks
From Market News Video
Fusion Pharma Shares Move Higher After Trial Collab With Merck For IGF-1R-Expressing Cancer Study
Tags Biotech Briefs Contracts
From Benzinga
3 Top Dividend Stocks to Buy Right Now
Tags CTXS MRK KMB
From Motley Fool
Lyft, GM Earnings Impress, Lifting Shares Ahead Of Uber's Report Slated For Later
Tags Media UBER FDA
From Benzinga
Investing in the Covid-19 vaccine companies? Here’s the great divide in the group
Tags JNJ MRK CAMOX
From MarketWatch
5 Brand-Name Stocks With 27% to 50% Upside, According to Wall Street
Tags AMD MRK ZM
From Motley Fool
Sharing A Ride To The Reopening: Uber, Lyft Earnings Could Offer Hints To Life Beyond The Pandemic
Tags Uber F Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.